Cargando…
Artificial Intelligent Multi-Modal Point-of-Care System for Predicting Response of Transarterial Chemoembolization in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) ranks the second most lethal tumor globally and is the fourth leading cause of cancer-related death worldwide. Unfortunately, HCC is commonly at intermediate tumor stage or advanced tumor stage, in which only some palliative treatment can be used to offer a limited ove...
Autores principales: | Sun, Zhongqi, Shi, Zhongxing, Xin, Yanjie, Zhao, Sheng, Jiang, Hao, Wang, Dandan, Zhang, Linhan, Wang, Ziao, Dai, Yanmei, Jiang, Huijie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634755/ https://www.ncbi.nlm.nih.gov/pubmed/34869272 http://dx.doi.org/10.3389/fbioe.2021.761548 |
Ejemplares similares
-
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis
por: Si, Tengfei, et al.
Publicado: (2022) -
Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma
por: Dai, Yanmei, et al.
Publicado: (2022) -
Bioaugmentation Technology for Treatment of Toxic and Refractory Organic Waste Water Based on Artificial Intelligence
por: Yanbo, Jiang, et al.
Publicado: (2021) -
Artificial intelligence to detect the femoral intertrochanteric fracture: The arrival of the intelligent-medicine era
por: Liu, Pengran, et al.
Publicado: (2022) -
Comparison of CalliSpheres(®) Microspheres Drug-eluting Beads and Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Shi, Zhongxing, et al.
Publicado: (2023)